2,461
Views
2
CrossRef citations to date
0
Altmetric
Research Article

CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturation

, , , , , , , & show all
Article: 2006529 | Received 24 Jul 2021, Accepted 09 Nov 2021, Published online: 22 Nov 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.